RO7486967
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO7486967, covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease. [Phase 1]